Financial reports
ARS
2023 FY
Annual report to shareholders
3 Apr 24
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
26 Apr 23
ARS
2022 FY
Annual report to shareholders
7 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
3 Apr 24
8-K
Departure of Directors or Certain Officers
26 Mar 24
8-K
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
7 Mar 24
8-K
Results of Operations and Financial Condition
5 Jan 24
8-K
Harvard Bioscience Announces Third Quarter 2023 Financial Results
7 Nov 23
8-K
Harvard Bioscience Announces Second Quarter 2023 Financial Results
8 Aug 23
8-K
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
20 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
15 May 23
8-K
Harvard Bioscience Announces First Quarter 2023 Financial Results
25 Apr 23
8-K
Other Events
13 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
8 Jun 22
S-8
Registration of securities for employees
19 May 21
S-8
Registration of securities for employees
6 Nov 20
S-8
Registration of securities for employees
30 May 19
S-8
Registration of securities for employees
1 Jun 18
S-3
Shelf registration
30 Apr 18
8-A12B/A
Registration of securities on exchange (amended)
2 Mar 18
S-8
Registration of securities for employees
5 Jun 17
S-8
Registration of securities for employees
5 Jun 15
S-3/A
Shelf registration (amended)
27 Apr 15
Proxies
DEFA14A
Additional proxy soliciting materials
3 Apr 24
DEF 14A
Definitive proxy
3 Apr 24
DEF 14A
Definitive proxy
5 Apr 23
DEF 14A
Definitive proxy
7 Apr 22
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEFA14A
Additional proxy soliciting materials
8 Apr 21
DEF 14A
Definitive proxy
8 Apr 21
DEFA14A
Additional proxy soliciting materials
26 May 20
DEF 14A
Definitive proxy
28 Apr 20
DEFA14A
Additional proxy soliciting materials
28 Apr 20
Other
UPLOAD
Letter from SEC
16 Aug 23
CORRESP
Correspondence with SEC
9 Aug 23
UPLOAD
Letter from SEC
28 Jul 23
SD
Conflict minerals disclosure
30 May 23
SD
Conflict minerals disclosure
20 May 22
SD
Conflict minerals disclosure
27 May 21
SD
Conflict minerals disclosure
29 May 20
SD
Conflict minerals disclosure
21 May 19
SD
Conflict minerals disclosure
25 May 18
EFFECT
Notice of effectiveness
10 May 18
Ownership
SC 13G
Leviticus Partners LP
19 Mar 24
4
Jennifer Cote
7 Mar 24
4
James W Green
7 Mar 24
SC 13G/A
Harvey Partners, LLC
14 Feb 24
SC 13G/A
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
14 Feb 24
SC 13G/A
B. Riley Asset Management, LLC
14 Feb 24
SC 13G/A
Harvard Apparatus Regenerative Technology, Inc.
13 Feb 24
SC 13G
BlackRock Inc.
26 Jan 24
SC 13G/A
Leviticus Partners LP
22 Jan 24
4
James W Green
3 Jan 24